Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

26 Oct 2016

Abstract excerpt

OBJECTIVES: Despite progress in identifying molecular pathophysiological processes in schizophrenia, valid biomarkers are lacking for both the disease and treatment response. METHODS: This comprehensive review summarises recent efforts to identify molecular mechanisms on the level of protein and gene expression and epigenetics, including DNA methylation, histone modifications and micro RNA expression....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Schizophrenia research and treatment
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27782767
DOI: 10.1080/15622975.2016.1224929

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsPMID 27782767Read ↗

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and geneticsSemantic proximity Read ↗

Advances in the genetics of schizophrenia: toward a network and pathway view for drug discovery.Semantic proximity Read ↗

Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity Read ↗

[Genetics and epigenetics of schizophrenia and other psychoses].Semantic proximity Read ↗

From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of SchizophreniaSemantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights.Semantic proximity Read ↗

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosisSemantic proximity Read ↗

Rethinking the Epigenetic Framework to Unravel the Molecular Pathology of Schizophrenia.Semantic proximity Read ↗

Schizophrenia as a disorder of molecular pathways.Semantic proximity Read ↗

Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.Semantic proximity Read ↗

Genetics of Schizophrenia: Historical Insights and Prevailing Evidence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.